Showing results (501-510 of 2,397) with videos related to

Sort By:
Pageof 240
Translational Lung Cancer Research|March 18, 2024
Outcomes following minimally invasive approaches vs. open extended lobectomy for non-small cell lung cancer: a propensity-matched analysis of the National Cancer DatabaseTangbing Chen, Ernest G Chan, Binhao Huang, et al.
Translational Lung Cancer Research|April 11, 2024
The role of RASA2 in predicting radioresistance in lung cancer through regulation of p53Jie Li, Yan Zong, Zhan Tuo, et al.
Translational Lung Cancer Research|April 11, 2024
The use of intravenous indocyanine green in minimally invasive segmental lung resections: a systematic reviewMaxim Peeters, Yanina Jansen, Jean H T Daemen, et al.
Translational Lung Cancer Research|April 11, 2024
Development of a haematological indices-based nomogram for prognostic prediction and immunotherapy response assessment in primary pulmonary lymphoepithelioma-like carcinoma patientsHui Sheng, Xin He, Zhiqiang Chen, et al.
Translational Lung Cancer Research|April 11, 2024
Biological characteristics and clinical treatment of pulmonary sarcomatoid carcinoma: a narrative reviewYuxuan Wei, Lei Wang, Zheng Jin, et al.
Translational Lung Cancer Research|April 11, 2024
Efficacy and safety of first-line PD-L1/PD-1 inhibitors in limited-stage small cell lung cancer: a multicenter propensity score matched retrospective studyJingyuan Xie, Ke Xu, Zijing Cai, et al.
Translational Lung Cancer Research|February 26, 2024
Potential synergistic effects of cranial radiotherapy and atezolizumab in non-small cell lung cancer: an analysis of individual patient data from seven prospective trialsTiantian Guo, Yue Zhou, Fei Liang, et al.
Translational Lung Cancer Research|May 13, 2024
Immunotherapy for patients with advanced non-small cell lung cancer harboring oncogenic driver alterations other than EGFR: a multicenter real-world analysisTian Tian, Yanying Li, Juan Li, et al.
Translational Lung Cancer Research|May 13, 2024
Molecular and immune characterization of Chinese early-stage non-squamous non-small cell lung cancer: a multi-omics cohort studyHaoxin Peng, Xiangrong Wu, Xiaoli Cui, et al.
Translational Lung Cancer Research|May 13, 2024
Entrectinib as first-line vs. second-line therapy in ROS1 fusion-positive non-small cell lung cancer: a cost-effectiveness analysisGengwei Huo, Ying Song, Xiongwen Chen, et al.
Pageof 240